Abstract
The epidemiology of cardiac complications related to HIV including cardiomyopathy, increased left ventricular mass, myocarditis, pericardial effusion, endocarditis, and malignancy are discussed. A large number of HIV-infected individuals will present with cardiac complications in the next decade as chronic viral infection, co-infections, drug therapy, and immunosuppression affect the heart. Understanding the nature and course of cardiac illness related to HIV infection will allow appropriate monitoring, early intervention and therapy, and will provide a baseline to evaluate the effects of new therapeutic regimens such as highly active antiretroviral therapy on the cardiovascular system.
| Original language | English |
|---|---|
| Pages (from-to) | 13-22 |
| Number of pages | 10 |
| Journal | Annals of the New York Academy of Sciences |
| Volume | 946 |
| State | Published - Dec 21 2001 |
| Externally published | Yes |
Fingerprint
Keywords
- Cardiomyopathy
- HIV infection
- Pericardial effusion
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
Cite this
Epidemiology of cardiovascular involvement in HIV disease and AIDS. / Fisher, Stacy D.; Lipshultz, Steven E.
In: Annals of the New York Academy of Sciences, Vol. 946, 21.12.2001, p. 13-22.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Epidemiology of cardiovascular involvement in HIV disease and AIDS
AU - Fisher, Stacy D.
AU - Lipshultz, Steven E
PY - 2001/12/21
Y1 - 2001/12/21
N2 - The epidemiology of cardiac complications related to HIV including cardiomyopathy, increased left ventricular mass, myocarditis, pericardial effusion, endocarditis, and malignancy are discussed. A large number of HIV-infected individuals will present with cardiac complications in the next decade as chronic viral infection, co-infections, drug therapy, and immunosuppression affect the heart. Understanding the nature and course of cardiac illness related to HIV infection will allow appropriate monitoring, early intervention and therapy, and will provide a baseline to evaluate the effects of new therapeutic regimens such as highly active antiretroviral therapy on the cardiovascular system.
AB - The epidemiology of cardiac complications related to HIV including cardiomyopathy, increased left ventricular mass, myocarditis, pericardial effusion, endocarditis, and malignancy are discussed. A large number of HIV-infected individuals will present with cardiac complications in the next decade as chronic viral infection, co-infections, drug therapy, and immunosuppression affect the heart. Understanding the nature and course of cardiac illness related to HIV infection will allow appropriate monitoring, early intervention and therapy, and will provide a baseline to evaluate the effects of new therapeutic regimens such as highly active antiretroviral therapy on the cardiovascular system.
KW - Cardiomyopathy
KW - HIV infection
KW - Pericardial effusion
UR - http://www.scopus.com/inward/record.url?scp=0035202403&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035202403&partnerID=8YFLogxK
M3 - Article
C2 - 11762981
AN - SCOPUS:0035202403
VL - 946
SP - 13
EP - 22
JO - Annals of the New York Academy of Sciences
JF - Annals of the New York Academy of Sciences
SN - 0077-8923
ER -